ClearPoint Neuro Inc (CLPT)
15.38
-0.11
(-0.71%)
USD |
NASDAQ |
Dec 31, 16:00
15.35
-0.03
(-0.20%)
Pre-Market: 20:00
ClearPoint Neuro SG&A Expense (Quarterly): 6.704M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 6.975M |
| Retractable Technologies Inc | 4.946M |
| InfuSystems Holdings Inc | 15.53M |
| Xtant Medical Holdings Inc | 19.38M |
| Catheter Precision Inc | 2.882M |